Gobivaz 100 mg/1 ml
Gobivaz 100 mg/1 ml is a medicine authorised by Swissmedic under authorisation number 70709. The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 30 July 2026 and the authorisation is limited until 29 July 2031. ATC code L04AB06 places the medicine in the group Immunosuppressants.
| Authorisation number | 70709 |
|---|---|
| Name | Gobivaz 100 mg/1 ml |
| Full name | Gobivaz 100 mg/1 ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Advanz Pharma Specialty Medicine Switzerland GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AB06 |
| First authorisation | 30 July 2026 |
| Authorisation validity | 29 July 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Gobivaz 100 mg/1 ml, Injektionslösung in einer Fertigspritze | B | 30 July 2026 |
| 2 | Gobivaz 50 mg/ 0.5 ml, Injektionslösung in einer Fertigspritze | B | 30 July 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 3 | 1 | Fertigspritze(n) | L04AB06 | 07.15.0. | B |
| 4 | 3 | Fertigspritze(n) | L04AB06 | 07.15.0. | B |
| 1 | 1 | Fertigspritze(n) | L04AB06 | 07.15.0. | B |
| 2 | 3 | Fertigspritze(n) | L04AB06 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Gobivaz 100 mg/1 ml authorised in Switzerland?
Yes. Gobivaz 100 mg/1 ml is authorised by Swissmedic under authorisation number 70709, data as of 01 September 2026. The authorisation is limited until 29 July 2031.
Which dispensing category does Gobivaz 100 mg/1 ml have?
Gobivaz 100 mg/1 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Gobivaz 100 mg/1 ml?
The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.